Parkinson Disease
Conditions
Interventions
The random sequence was generated through the True Random Number Service program, by a blind researcher. Each number was placed, respecting the sequence order, in opaque envelopes. Once participants w
E02.190.525.186
Sponsors
Instituto de Ciências da Saúde - Universidade Federal da Bahia
Instituto de Ciências da Saúde - Universidade Federal da Bahia
Eligibility
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: Being on regular medication for Parkinson's Disease; be in “on” period; be aged 50 years or older; present stage 2, 2.5 or 3 according to the modified Hoehn and Yahr Classification.
Exclusion criteria
Exclusion criteria: Present neurodegenerative diseases excluding Parkinson's disease, dementia, musculoskeletal diseases that make it impossible to practice physical activity; uncontrolled chronic diseases (hypertension, diabetes mellitus, chronic pain); unstable cardiovascular diseases (acute heart failure; recent myocardial infarction; unstable angina and uncontrolled arrhythmias); use of alcohol and other toxic substances; practicing or having practiced a physical exercise program in the last 6 months; or if you participate or have participated in regular resistance training (eg 2-3 times a week) in the previous 12 months; more than 4 absences during the intervention protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find an improvement in the maximum inspiratory pressure, evaluated by manovacuometry with an increase of at least 20%. Data collected 2 days after the intervention and 2 days after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find an improvement in maximum expiratory pressure, assessed by manovacuometry with an increase of at least 20%. Data collected 2 days after the intervention and 2 days after the intervention.;It is expected to find an improvement in forced vital capacity, assessed by spirometry with an increase of at least 10%. Data collected 2 days after the intervention and 2 days after the intervention.;It is expected to find an improvement in the forced expiratory volume in the first second, evaluated by spirometry with an increase of at least 5%. Data collected 2 days after the intervention and 2 days after the intervention.;It is expected to find an improvement in peak expiratory flow, assessed by spirometry with an increase of at least 5%. Data collected 2 days after the intervention and 2 days after the intervention.;It is expected to find an improvement in chest expansion, assessed by cirtometry with an increase of at least 5%. Data collected 2 days after the intervention and 2 days after the intervention.;It is expected to find an improvement in aerobic performance, assessed by the 6-minute walk test with an increase of at least 10%. Data collected 2 days after the intervention and 2 days after the intervention. | — |
Countries
Brazil
Contacts
Public ContactCristina Barreto
Instituto de Ciências da Saúde - Universidade Federal da Bahia
Outcome results
None listed